UNSPSC 51401802: Clotiazepam

This classification denotes a sedative and hypnotic with the molecular formula C16H15ClN2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZCN055599V, chemically known as 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2h-thieno(2,3-e)-1,4-diazepin-2-one but generally known as clotiazepam, which bears US NIH Compound Identifier 2811. European Medicines Agency schedules Clotiazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06773MIG.

UNSPSC 51401802 Clotiazepam, a Commodity code, shows minimal alignment with recent state and local procurement activity under its nominal classification. The single posted opportunity in the recent record is Seminole County, Florida's IFB 60459723LAS, which solicits naloxone and safe drug deactivation systems—products wholly outside the scope of clotiazepam, a benzodiazepine pharmaceutical. The mismatch suggests either a tagging error in the source data or that clotiazepam procurement does not surface regularly in state and local competitive bidding channels. State and local governments that do acquire clotiazepam typically do so through pharmaceutical supply contracts under health department or corrections-system accounts, often leveraging existing cooperative purchasing vehicles or standing master agreements rather than discrete solicitations.

Seminole County's July 2026 IFB represents the only recent opportunity indexed to this code, and it is plainly unrelated to clotiazepam. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, via competitive sealed bid with a response deadline of July 26, 2023. Bidders were required to provide unit costs, maintain specified insurance and drug-free workplace certifications, and comply with E-Verify requirements; the contract carried a two-year initial term with a one-year renewal option and was potentially FEMA-funded. Given the absence of clotiazepam-specific opportunities in the available record and the absence of a pattern across multiple issuing bodies or states, this code does not present clear procurement signals for current pursuit.